This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion
by Zacks Equity Research
Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion are part of the Zacks Market Edge blog.
5 Top Small Cap Stocks to Buy Now
by Tracey Ryniec
How to screen for the best small cap stocks using the Zacks Rank.
Down -5.13% in 4 Weeks, Here's Why You Should You Buy the Dip in TriMas (TRS)
by Zacks Equity Research
The heavy selling pressure might have exhausted for TriMas (TRS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Why Is Century (CENX) Up 18.1% Since Last Earnings Report?
by Zacks Equity Research
Century (CENX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) Up 2.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
TriMas (TRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Timken (TKR) Tops Q1 Earnings Estimates, Raises '24 View
by Zacks Equity Research
Timken (TKR) witnesses year-over-year declines in Q1 revenues and earnings from the record levels reported last year due to low volumes.
TriMas (TRS) Q1 Earnings & Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
TriMas' (TRS) Q1 top and bottom lines reflect organic growth in both aerospace and packaging segments.
Weakness in Specialty Products, High Costs Ail TriMas (TRS)
by Zacks Equity Research
TriMas' (TRS) results will bear the brunt of the recent weakness in industrial cylinder demand, as well as high costs and labor shortages.
TriMas (TRS) Earnings Miss Estimates in Q4, Revenues Rise Y/Y
by Zacks Equity Research
TriMas' (TRS) Q4 top line reflects organic growth in the aerospace and defense business.
ESAB Corporation (ESAB) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Esab (ESAB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ESAB Corporation (ESAB) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Esab (ESAB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is TriMas (TRS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy AB SKF (SKFRY) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas
by Zacks Equity Research
Zacks Industry Outlook Highlights Norsk Hydro ASA, AB SKF, ESAB, Century Aluminum and TriMas
5 Metal Fabrication Stocks to Watch in a Challenging Industry
by Madhurima Das
Low order levels cloud the near-term prospects of the Zacks Metal Products - Procurement and Fabrication industry. However, the likes of NHYDY, SKFRY, ESAB, CENX and TRS seem well-poised to tide over the hurdles.
TriMas (TRS) Expands Life Sciences' Cleanroom Capabilities
by Zacks Equity Research
TriMas (TRS) expands the cleanroom capabilities of its Life Sciences division as part of its long-term strategic enhancement.
TriMas (TRS) Stock Down 7% in a Year: Will It Bounce Back in 2024?
by Zacks Equity Research
TriMas' (TRS) results and price performance have been mirroring the persisting weakness in packaging demand, escalating raw material costs and supply-chain constraints.
Timken (TKR) Up 2.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Timken (TKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TriMas (TRS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
TriMas (TRS) delivered earnings and revenue surprises of 1.79% and 4.77%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Kaiser Aluminum (KALU) Beats Q3 Earnings Estimates
by Zacks Equity Research
Kaiser (KALU) delivered earnings and revenue surprises of 15% and 1.83%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Investors Should Avoid TriMas (TRS) Stock Now
by Zacks Equity Research
TriMas (TRS) results continue to be impacted by a slowdown in demand in its packaging segment due to inflationary pressures, high interest rates and cost inflation.
Worthington Industries (WOR) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Worthington (WOR) delivered earnings and revenue surprises of 3.52% and 11.81%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
TriMas (TRS) Stock Down 12% in a Year: Is a Revival Likely?
by Zacks Equity Research
Weak packaging demand, escalating raw material costs and supply-chain constraints are impacting TriMas' (TRS) results and price performance.
TriMas (TRS) Q2 Earnings Match Estimates, Sales Dip Y/Y
by Zacks Equity Research
TriMas' (TRS) Q2 earnings bear the brunt of weak demand in the packaging segment owing to customer destocking and lower spending.